000 | 01668 a2200433 4500 | ||
---|---|---|---|
005 | 20250517222030.0 | ||
264 | 0 | _c20181018 | |
008 | 201810s 0 0 eng d | ||
022 | _a2169-141X | ||
024 | 7 |
_a10.1080/21691401.2018.1476375 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuo, Chen | |
245 | 0 | 0 |
_aLong term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. _h[electronic resource] |
260 |
_bArtificial cells, nanomedicine, and biotechnology _cNov 2018 |
||
300 |
_a1349-1363 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArterial Pressure _xdrug effects |
650 | 0 | 4 |
_aBlood Substitutes _xadverse effects |
650 | 0 | 4 | _aBlood Transfusion |
650 | 0 | 4 | _aBlood Volume |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aCarbonic Anhydrases _xchemistry |
650 | 0 | 4 |
_aCatalase _xchemistry |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aComplement C3a _xmetabolism |
650 | 0 | 4 |
_aHemoglobins _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin M _xblood |
650 | 0 | 4 |
_aNanomedicine _xmethods |
650 | 0 | 4 | _aProtein Multimerization |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aSuperoxide Dismutase _xchemistry |
700 | 1 | _aChang, Thomas Ming Swi | |
773 | 0 |
_tArtificial cells, nanomedicine, and biotechnology _gvol. 46 _gno. 7 _gp. 1349-1363 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/21691401.2018.1476375 _zAvailable from publisher's website |
999 |
_c28501862 _d28501862 |